Sponsored Links
| FDA Approves New Drug For Pain That Persists After Shingles |
 |
 |
 |
| Medical News - Dermatology | |||
|
The US Food and Drug Administration (FDA) announced yesterday that it has approved Qutenza (capsaicin) 8% patch for the treatment of post-herpetic neuralgia (PHN), an often excruciating pain that can persist for weeks, months and even years in 10 to 15 per cent of people who get shingles... Read more: Dermatology News From Medical News Today
|